Contribution of Known and Unknown Susceptibility Genes to Early-Onset Diabetes in Scandinavia
Evidence for Heterogeneity
- Cecilia M. Lindgren1,
- Elisabeth Widén2,
- Tiinamaija Tuomi13,
- Haiyan Li1,
- Peter Almgren1,
- Timo Kanninen14,
- Olle Melander1,
- Jianping Weng1,
- Markku Lehto1 and
- Leif C. Groop1
- 1Department of Endocrinology, Wallenberg laboratory, Malmö University Hospital, Malmö, Sweden
- 2Finnish Genome Center, University of Helsinki, Helsinki, Finland
- 3Department of Internal Medicine, Helsinki University Central Hospital, Helsinki, Finland
- 4Biocomputing O/Y, Helsinki, Finland
Abstract
In an attempt to identify novel susceptibility genes predisposing to early-onset diabetes (EOD), we performed a genome-wide scan using 433 markers in 222 individuals (119 with diabetes) from 29 Scandinavian families with ≥2 members with onset of diabetes ≤45 years. The highest nonparametric linkage (NPL) score, 2.7 (P < 0.01), was observed on chromosome 1p (D1S473/D1S438). Six other regions on chromosomes 3p, 7q, 11q, 18q, 20q, and 21q showed a nominal P value <0.05. Of the EOD subjects in these 29 families, 20% were GAD antibody positive and 68% displayed type 1 diabetes HLA risk alleles (DQB*02 or 0302). Mutations in maturity-onset diabetes of the young (MODY) 1–5 genes and the A3243G mitochondrial DNA mutation were detected by single-strand conformation polymorphism and direct sequencing. To increase homogeneity, we analyzed a subsample of five families with autosomal dominant inheritance of EOD (greater than or equal to two members with age at diagnosis ≤35 years). The highest NPL scores were found on chromosome 1p (D1S438–D1S1665; NPL 3.0; P < 0.01) and 16q (D16S419; NPL 2.9; P < 0.01). After exclusion of three families with MODY1, MODY3, and mitochondrial mutations, the highest NPL scores were observed on chromosomes 1p (D1S438; NPL 2.6; P < 0.01), 3p (D3S1620; NPL 2.2; P < 0.03), 5q (D5S1465; NPL 2.1; P < 0.03), 7q (D7S820; NPL 2.0; P < 0.03), 18q (D18S535; NPL 1.9; P < 0.04), 20q (D20S195; NPL 2.5; P < 0.02), and 21q (D21S1446; NPL 2.2; P < 0.03). We conclude that considerable heterogeneity exists in Scandinavian subjects with EOD; 24% had MODY or maternally inherited diabetes and deafness, and ∼60% were GAD antibody positive or had type 1 diabetes-associated HLA genotypes. Our data also point at putative chromosomal regions, which could harbor novel genes that contribute to EOD.
Footnotes
-
Address correspondence to Prof. Leif C. Groop and reprint requests to Cecilia M. Lindgren, Department of Endocrinology, Wallenberg Laboratory, Malmö University Hospital, S-205 02 Malmö, Sweden. E-mail: leif.groop{at}endo.mas.lu.se and cecilia.lindgren{at}endo.mas.lu.se.
Received for publication 24 January 2001 and accepted in revised form 28 January 2002.
Additional information for this article can be accessed at http://diabetes.diabetesjournals.org.
C.M.L. and E.W. contributed equally to this work.
AAD, age at diagnosis; EOD, early-onset diabetes; GADA, GAD antibody; GCK, glucokinase; HLOD, heterogeneity logarithm of odds; IGT, impaired glucose tolerance; LOD, logarithm of odds; MIDD, maternally inherited diabetes and deafness; MODY, maturity-onset diabetes of the young; NPL, nonparametric linkage.
- DIABETES











